Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heavy chain diseases.

Dietlind L Wahner-Roedler1, Robert A Kyle

  • 1Division of General Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. wahnerroedler.dietlind@mayo.edu

Best Practice & Research. Clinical Haematology
|July 20, 2005
PubMed
Summary

Heavy chain diseases (HCDs) are rare B-cell cancers producing abnormal immunoglobulin heavy chains. Diagnosis involves detecting deleted heavy chains without light chains, with variable prognoses and limited treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Role of Battlefield Acupuncture in Emergency Department Settings: A Systematic Review of Randomized Controlled Trials.

Journal of integrative and complementary medicine·2026
Same author

Association of hormone therapy and outcomes in COVID-19.

Menopause (New York, N.Y.)·2025
Same author

Effect of Reiki on Measures of Well-Being in Low-Income Patients with Mental Health Diagnoses.

Global advances in integrative medicine and health·2025
Same author

Use of Complementary and Integrative Medicine Among Low-Income Persons With Mental Health Disorders.

Mayo Clinic proceedings. Innovations, quality & outcomes·2025
Same author

Effect of Aromatherapy on Perceived Mental Health Parameters for Academic Department Workers Working From Home During the COVID-19 Pandemic: A Pilot Study.

Global advances in integrative medicine and health·2024
Same author

Complementary and alternative medicine for long COVID: a systematic review of randomized controlled trials.

Therapeutic advances in chronic disease·2023

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Heavy chain diseases (HCDs) are uncommon B-cell lymphoproliferative disorders.
  • Characterized by truncated monoclonal immunoglobulin heavy chains lacking light chains.
  • Three main classes exist: alpha-HCD (most common), gamma-HCD, and mu-HCD, each with distinct features.

Purpose of the Study:

  • To summarize the characteristics, diagnosis, and treatment of heavy chain diseases.
  • To differentiate HCDs based on immunoglobulin class and associated lymphoma types.
  • To highlight the diagnostic criteria and prognostic variability of HCDs.

Main Methods:

  • Review of literature on heavy chain diseases.
  • Analysis of clinical presentations and histopathologic features.
  • Description of diagnostic methods, including serum and urine analysis.

Main Results:

  • Alpha-HCD presents uniformly as extranodal marginal-zone lymphoma.
  • Gamma- and mu-HCDs show variable presentations as other non-Hodgkin lymphomas or chronic lymphocytic leukemia.
  • Diagnosis requires identifying deleted heavy chains without bound light chains.

Conclusions:

  • HCDs represent a spectrum of B-cell malignancies with distinct subclass characteristics.
  • Early-stage alpha-HCD may respond to antibiotics, while other HCDs lack standardized treatments.
  • Prognosis for HCDs is variable, necessitating further research into effective therapeutic strategies.

Related Experiment Videos